Regional Digestive System Neuroendocrine Tumor G1

Regional Digestive System Neuroendocrine Tumor G1 — Trials · CancerIndex

Clinical trials

Registered studies

8 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01841736	Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors	active not recruiting	Phase 2	171	National Cancer Institute (NCI)NIH	2	Aug 28, 2026	clinicaltrials
NCT00454363	Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer	completed	Phase 2	52	National Cancer Institute (NCI)NIH	1	Apr 3, 2020	clinicaltrials
NCT01010126	Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer	completed	Phase 2	252	National Cancer Institute (NCI)NIH	2	Jan 25, 2019	clinicaltrials
NCT00084461	Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors

Data updated 22 days agoSource updated Aug 28, 2026source: clinicaltrials